{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/1890931931",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1788999168"
  ],
  "child": [
    "http://id.who.int/icd/release/11/2024-01/mms/1585600114",
    "http://id.who.int/icd/release/11/2024-01/mms/296753000",
    "http://id.who.int/icd/release/11/2024-01/mms/1890931931/other",
    "http://id.who.int/icd/release/11/2024-01/mms/1890931931/unspecified"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#1890931931",
  "code": "8D87.0",
  "source": "http://id.who.int/icd/entity/1890931931",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Multiple system atrophy"
  },
  "definition": {
    "@language": "en",
    "@value": "Multiple system atrophy (MSA) is a rare neurodegenerative disorder characterised by varied combinations of parkinsonian, cerebellar, autonomic (erectile dysfunction, bladder dysfunction, orthostatic hypotension) and pyramidal features. The disease belongs to the group of alpha-synucleinopathies, a group of diseases characterised by aggregation of alpha-synuclein in affected brain regions. There are two different types: MSA-P (with parkinsonism) and MSA-C (with cerebellar dysfunction)."
  }
}